Category: Laboratories

Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study

Moderna Completes Enrollment of Phase 3 COVE Study of mRNA Vaccine Against COVID-19 (mRNA-1273)

Mitigating Impacts of a Global Pandemic in the Clinical Development Space

Enhancing Communication Between Clinical Trial Sites and the Central Lab During a Global Pandemic

PPD’s Patient Data Dashboard: Moving Data Review Forward Today and Beyond

How COVID-19 is Changing the Approach for the Vaccine Development Process

Moderna Announces Phase 3 COVE Study of mRNA Vaccine Against COVID-19 (mRNA-1273) Begins

Implementing the Estimands Framework in Clinical Trials

Virtual Lab Quality Audits: Are They Here to Stay?